NDSN vs REPL · P/E 31, rev $2.69B vs $825.7M cap
Nordson Corporation (NDSN) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
REPL does not have a complete income-statement cache yet.
NDSN currently screens at market cap $16.17B and trailing P/E 31.0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the NDSN and REPL stock pages for the full models.
Not investment advice.